Evidence mapPaperPMID 42377912Full record

ReviewFEMS microbiology reviews2026

Feeding the invaders: how metabolic imbalance shapes infection and biofilm development.

Sahil Mahajan, Sarah MacDowell, Cortney Mitchem, Evan Alexander, Daniel J Wozniak

Abstract readReview
In one paragraph

Review in FEMS microbiology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sahil MahajanDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, United States.
Sarah MacDowellDivision of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, United States.
Cortney MitchemDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, United States.
Evan AlexanderDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, United States.
Daniel J WozniakDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210, United States.ORCID 0000-0003-4592-4816

Funding

Molecular determinants and functions of bacterial polysaccharide cellular localizationR01AI183692 · UNIVERSITY OF WASHINGTON · 2025 to 2025
$784k
Cooperation and antagonism in polymicrobial infectionR01AI186380 · OHIO STATE UNIVERSITY · 2025 to 2025
$734k
Cure Cystic Fibrosis Columbus (C3) Research Development Program McCoy24RoNationwide Children's HospitalNIAID NIH HHS R01 AI183692NIAID NIH HHS R01 AI186380NIAID NIH HHS R41 AI069865NIH HHS R01AI183692NIH HHS R01AI186380NIH HHS R01AI69865Public Health grants
6 · The paper itself

Abstract

Infectious and metabolic disorders have risen sharply and pose a significant threat to human populations worldwide. Despite being deemed unrelated, mounting evidence indicates that metabolic disorders markedly heightened both the likelihood and severity of infectious disease. The mechanism underlying this association is only beginning to be appreciated and involves a complex interaction between altered metabolic state, pathogen virulence mechanisms, and immune effector pathways. Here, we highlight that a dysregulated metabolic environment disrupts homeostasis, creating a nutrient-rich, immunocompromised milieu that promotes bacterial survival and replication in the host. Metabolic dysfunction is also discussed as a factor that promotes bacterial persistence by altering reactive oxygen species production and inducing tissue hypoxia, conditions that favor biofilm growth. We also examine how bacteria directly exploit nutrient surplus in metabolic diseases to boost their virulence programs and biofilm formation. Moreover, given the ever-increasing problem of antibiotic resistance, we discuss how metabolic diseases contribute to this challenge. Collectively, uncovering how metabolic disorders increase chronic or recurrent infections can guide the development of effective treatment strategies.

Indexed as

BacteriaBacterial InfectionsBiofilmsMetabolic DiseasesAnimalsHost-Pathogen InteractionsHumansVirulencebacterial persistencebiofilmsimmune dysfunctioninflammationmetabolic diseases

Identifiers

PMID42377912
PMCPMC13458953

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.